Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience

European Neuropsychopharmacology

Volumn 24, Issue 3, 2014, Pages 410-419

  Fogaca M V ^a   Reis, F M C V ^a   Campos, A C ^a,b   Guimaraes F S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

5HT1A receptors; Anxiety; Cannabidiol; Glucocorticoids; Prefrontal cortex; Stress

Indexed keywords

ANXIOLYTIC AGENT; CANNABIDIOL; ENZYME INHIBITOR; METYRAPONE; N-(2-(4-(2-METHOXYPHENYL)-1-PIPERAZINYL)ETHYL)-N-(2-PYRIDINYL)CYCLOHEXANECARBOXAMIDE; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN 1 ANTAGONIST; SEROTONIN 1A RECEPTOR;

ANIMAL; ANXIETY; CONDITIONING; DOSE RESPONSE; DRUG EFFECTS; DRUG THERAPY; EXERCISE; EXPLORATORY BEHAVIOR; FEAR; MALE; MAZE TEST; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; RAPHE NUCLEUS; TIME; WISTAR RAT;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; CANNABIDIOL; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EXPLORATORY BEHAVIOR; FEAR; MALE; MAZE LEARNING; METYRAPONE; PIPERAZINES; PREFRONTAL CORTEX; PYRIDINES; RAPHE NUCLEI; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; RESTRAINT, PHYSICAL; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 84894375170     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2013.10.012     Document Type: Article

References (52)

1. Andrade R. Serotonergic regulation of neuronal excitability in the prefrontal cortex. Neuropharmacology 2011, 61(3):382-386.
2. Bergamaschi M.M., Queiroz R.H., Chagas M.H., de Oliveira D.C., De Martinis B.S., Kapczinski F., Quevedo J., Roesler R., Schroder N., Nardi A.E., Martin-Santos R., Hallak J.E., Zuardi A.W., Crippa J.A. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology 2011, 36(6):1219-1226.
3. Bisogno T., Hanus L., De Petrocellis L., Tchilibon S., Ponde D.E., Brandi I., Moriello A.S., Davis J.B., Mechoulam R., Di Marzo V. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br. J. Pharmacol. 2001, 134(4):845-852.
4. Bitencourt R.M., Pamplona F.A., Takahashi R.N. Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. Eur. Neuropsychopharmacol. 2008, 18(12):849-859.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
6. Calvo N., Martijena I.D., Molina V.A., Volosin M. Metyrapone pretreatment prevents the behavioral and neurochemical sequelae induced by stress. Brain Res. 1998, 800(2):227-235.
7. Campos A.C., Guimaraes F.S. Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology (Berl) 2008, 199(2):223-230.
8. Campos A.C., Guimaraes F.S. Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33(8):1517-1521.
9. Campos A.C., Soares V.de Paula, Carvalho M.C., Ferreira F.R., Vicente M.A., Brandao M.L., Zuardi A.W., Zangrossi H., Guimaraes F.S. Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats. Psychopharmacology (Berl) 2013, 226(1):13-24.
10. Campos A.C., Ferreira F.R., Guimaraes F.S. Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors. J. Psychiatr. Res. 2012, 46(11):1501-1510.
11. Campos A.C., Ferreira F.R., Guimaraes F.S., Lemos J.I. Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience. Neuroscience 2010, 167(2):238-246.
12. Campos A.C., Moreira F.A., Gomes F.V., Del Bel E.A., Guimaraes F.S. Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2012, 367(1607):3364-3378.
13. Campos A.C., Ortega Z., Palazuelos J., Fogaca M.V., Aguiar D.C., Diaz-Alonso J., Ortega-Gutierrez S., Vazquez-Villa H., Moreira F.A., Guzman M., Galve-Roperh I., Guimaraes F.S. The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system. Int. J. Neuropsychopharmacol. 2013, 16(6):1407-1419.
14. Casanovas J.M., Hervas I., Artigas F. Postsynaptic 5-HT1A receptors control 5-HT release in the rat medial prefrontal cortex. Neuroreport 1999, 10(7):1441-1445.
15. Celada P., Puig M.V., Casanovas J.M., Guillazo G., Artigas F. Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABA(A), and glutamate receptors. J. Neurosci. 2001, 21(24):9917-9929.
16. Cerqueira J.J., Taipa R., Uylings H.B.M., Almeida O.F.X., Sousa N. Specific configuration of dendritic degeneration in pyramidal neurons of the medial prefrontal cortex induced by differing corticosteroid regimens. cereb. cortex. 2007, 17(9):1998-2003.
17. Davis S., Renaudineau S., Poirier R., Poucet B., Save E., Laroche S. The formation and stability of recognition memory: what happens upon recall?. Front. Behav. Neurosci. 2010, 4:177.
18. de Visser L., Baars A.M., van 't Klooster J., van den Bos R. Transient inactivation of the medial prefrontal cortex affects both anxiety and decision-making in male wistar rats. Front. Neurosci. 2011, 5:102.
19. Diorio D., Viau V., Meaney M.J. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J. Neurosci. 1993, 13(9):3839-3847.
20. Esposito G., Scuderi C., Valenza M., Togna G.I., Latina V., De Filippis D., Cipriano M., Carratu M.R., Iuvone T., Steardo L. Cannabidiol reduces Abeta-induced neuroinflammation and promotes hippocampal neurogenesis through PPARgamma involvement. PLoS One 2011, 6(12):e28668.
21. Fogaca M.V., Aguiar D.C., Moreira F.A., Guimaraes F.S. The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior. Neuropharmacology 2012, 63(2):202-210.
22. Fogaca M.V., Gomes F.V., Moreira F.A., Guimaraes F.S., Aguiar D.C. Effects of glutamate NMDA and TRPV1 receptor antagonists on the biphasic responses to anandamide injected into the dorsolateral periaqueductal grey of Wistar rats. Psychopharmacology (Berl) 2013, 226(3):579-587.
23. Garcia-Iglesias B.B., Mendoza-Garrido M.E., Gutierrez-Ospina G., Rangel-Barajas C., Noyola-Diaz M., Terron J.A. Sensitization of restraint-induced corticosterone secretion after chronic restraint in rats: involvement of 5-HT(7) receptors. Neuropharmacology 2013, 71:216-227.
24. Gomes F.V., Resstel L.B., Guimaraes F.S. The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors. Psychopharmacology (Berl) 2011, 213(2-3):465-473.
25. Guimaraes F.S., Chiaretti T.M., Graeff F.G., Zuardi A.W. Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology (Berl) 1990, 100(4):558-559.
26. Inoue T., Tsuchiya K., Koyama T. Serotonergic activation reduces defensive freezing in the conditioned fear paradigm. Pharmacol. Biochem. Behav. 1996, 53(4):825-831.
27. Izzo A.A., Borrelli F., Capasso R., Di Marzo V., Mechoulam R. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol. Sci. 2009, 30(10):515-527.
28. Jinks A.L., McGregor I.S. Modulation of anxiety-related behaviours following lesions of the prelimbic or infralimbic cortex in the rat. Brain Res. 1997, 772(1-2):181-190.
29. Laaris N., Haj-Dahmane S., Hamon M., Lanfumey L. Glucocorticoid receptor-mediated inhibition by corticosterone of 5-HT1A autoreceptor functioning in the rat dorsal raphe nucleus. Neuropharmacology 1995, 34(9):1201-1210.
30. Lemos J.I., Resstel L.B., Guimaraes F.S. Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats. Behav. Brain Res. 2010, 207(1):105-111.
31. Lisboa S.F., Stecchini M.F., Correa F.M., Guimaraes F.S., Resstel L.B. Different role of the ventral medial prefrontal cortex on modulation of innate and associative learned fear. Neuroscience 2010, 171(3):760-768.
32. Maier S.F., Watkins L.R. Role of the medial prefrontal cortex in coping and resilience. Brain Res. 2010, 1355:52-60.
33. Maier S.F., Amat J., Baratta M.V., Paul E., Watkins L.R. Behavioral control, the medial prefrontal cortex, and resilience. Dialogues Clin. Neurosci. 2006, 8(4):397-406.
34. Mechoulam R., Gaoni Y. Hashish. IV. The isolation and structure of cannabinolic cannabidiolic and cannabigerolic acids. Tetrahedron 1965, 21(5):1223-1229.
35. Mechoulam R., Peters M., Murillo-Rodriguez E., Hanus L.O. Cannabidiol-recent advances. Chem. Biodivers. 2007, 4(8):1678-1692.
36. Millan M.J. The neurobiology and control of anxious states. Prog. Neurobiol. 2003, 70(2):83-244.
37. Miller M.M., Morrison J.H., McEwen B.S. Basal anxiety-like behavior predicts differences in dendritic morphology in the medial prefrontal cortex in two strains of rats. Behav. Brain Res. 2012, 229(1):280-288.
38. Moreira F.A., Aguiar D.C., Guimaraes F.S. Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006, 30(8):1466-1471.
39. Padovan C.M., Del Bel E.A., Guimaraes F.S. Behavioral effects in the elevated plus maze of an NMDA antagonist injected into the dorsal hippocampus: influence of restraint stress. Pharmacol. Biochem. Behav. 2000, 67(2):325-330.
40. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates 2005, Elsevier Academic Press, Amsterdam.
41. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 1985, 14(3):149-167.
42. Radley J.J., Rocher A.B., Miller M., Janssen W.G., Liston C., Hof P.R., McEwen B.S., Morrison J.H. Repeated stress induces dendritic spine loss in the rat medial prefrontal cortex. Cereb. Cortex 2006, 16(3):313-320.
43. Resstel L.B., Joca S.R., Moreira F.A., Correa F.M., Guimaraes F.S. Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats. Behav. Brain Res. 2006, 172(2):294-298.
44. Russo E.B., Burnett A., Hall B., Parker K.K. Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochem. Res. 2005, 30(8):1037-1043.
45. Soares V.de P., Campos A.C., Bortoli V.C., Zangrossi H., Guimaraes F.S., Zuardi A.W. Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors. Behav. Brain Res. 2010, 213(2):225-229.
46. Solati J., Salari A.A., Bakhtiari A. 5HT(1A) and 5HT(1B) receptors of medial prefrontal cortex modulate anxiogenic-like behaviors in rats. Neurosci. Lett. 2011, 504(3):325-329.
47. Stern C.A., Gazarini L., Takahashi R.N., Guimaraes F.S., Bertoglio L.J. On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment. Neuropsychopharmacology 2012, 37(9):2132-2142.
48. Treit D., Robinson A., Rotzinger S., Pesold C. Anxiolytic effects of serotonergic interventions in the shock-probe burying test and the elevated plus-maze test. Behav. Brain Res. 1993, 54(1):23-34.
49. Vidal-Gonzalez I., Vidal-Gonzalez B., Rauch S.L., Quirk G.J. Microstimulation reveals opposing influences of prelimbic and infralimbic cortex on the expression of conditioned fear. Learn. Mem. 2006, 13(6):728-733.
50. Zanelati T.V., Biojone C., Moreira F.A., Guimaraes F.S., Joca S.R. Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors. Br. J. Pharmacol. 2010, 159(1):122-128.
51. Zuardi A.W. Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. Rev. Bras. Psiquiatr. 2008, 30(3):271-280.
52. Zuardi A.W., Cosme R.A., Graeff F.G., Guimaraes F.S. Effects of ipsapirone and cannabidiol on human experimental anxiety. J. Psychopharmacol. 1993, 7(Supp1. l):82-88.